VSE knjižnice (vzajemna bibliografsko-kataložna baza podatkov COBIB.SI)
-
Efficacy of tyrosine kinase inhibitors inroutine clinical practice : epidermal growth factor mutations and their implicationsOvčariček, Tanja ...Background: Activating mutations in the epidermal growth factor (EGFR) gene confer sensitivity to the tyrosine kinase inhibitors (TKIs)in patients with advanced nonsmall cell lung cancer (NSCLC). TKI ... treatment efficacy and EGFR mutation implications were evaluatedin clinically selected advanced NSCLC patients treated with TKIs in routine clinical practice.Materials and Methods: A retrospective chart review for clinicopathological characteristics and mutation status (EGFR, KRAS) analysisof 40 consecutive patients treated with TKIs between 2005 and 2010 was performed.Statistical Analysis Used: PFS and OS were estimated by the Kaplan-Meier method, the log-rank test was used to test for differences.The strength of the associations between the EGFR mutation status and clinicopathological characteristics were tested with the Mann-Whitney U-test or the Kruskal-Wallis H-test.Results: The prevalence of EGFR mutations was 45% with a predominance of deletion mutations in exon 19 (55.5%). Significantcorrelations between gender, histology, and EGFR mutations were observed. Median progression-free survival (mPFS) for the entiregroup of patients was 8.7 months and median overall survival (mOS) was not yet reached. Patients with EGFR mutant tumors derivedsignificantly higher benefit from TKI therapy compared to patients with mutation-negative disease; with mPFS of 22.0 vs. 3.2 months(HR: 3.9, 95% CI 1.569.89) and with a trend towards better OS (probability of survival at 12 months 82.0 vs. 63.0%, P = 0.080).Conclusion: We demonstrated that screening for EGFR mutations is reliable in a routine clinical setting and might allow for a betterselection of NSCLC patients for anti-EGFR TKI therapy.Vir: Journal of Cancer Research and Therapeutics. - ISSN 0973-1482 (Vol. 9, iss. 2, Apr.-Jun. 2013, str. 261-266)Vrsta gradiva - članek, sestavni delLeto - 2013Jezik - angleškiCOBISS.SI-ID - 1603963
Avtor
Ovčariček, Tanja |
Čufer, Tanja, 1955- |
Kern, Izidor |
Sodja, Eva |
Sadikov, Aleksander, računalništvo
Teme
epidermalni rastni faktor |
mutacije |
nedrobnocelični pljučni rak |
klinična praksa |
epidermal growth factor mutations |
non-small cell lung cancer |
routine clinical practice |
tyrosine kinase inhibitors
vir: Journal of Cancer Research and Therapeutics. - ISSN 0973-1482 (Vol. 9, iss. 2, Apr.-Jun. 2013, str. 261-266)
Vnos na polico
Trajna povezava
- URL:
Faktor vpliva
Dostop do baze podatkov JCR je dovoljen samo uporabnikom iz Slovenije. Vaš trenutni IP-naslov ni na seznamu dovoljenih za dostop, zato je potrebna avtentikacija z ustreznim računom AAI.
Leto | Faktor vpliva | Izdaja | Kategorija | Razvrstitev | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Baze podatkov, v katerih je revija indeksirana
Ime baze podatkov | Področje | Leto |
---|
Povezave do osebnih bibliografij avtorjev | Povezave do podatkov o raziskovalcih v sistemu SICRIS |
---|---|
Ovčariček, Tanja | 54060 |
Čufer, Tanja, 1955- | 12179 |
Kern, Izidor | 15781 |
Sodja, Eva | 28517 |
Sadikov, Aleksander, računalništvo | 20389 |
Vir: Osebne bibliografije
in: SICRIS
Izberite prevzemno mesto:
Prevzem gradiva po pošti
Naslov za dostavo:
Med podatki člana manjka naslov.
Storitev za pridobivanje naslova trenutno ni dostopna, prosimo, poskusite še enkrat.
S klikom na gumb "V redu" boste potrdili zgoraj izbrano prevzemno mesto in dokončali postopek rezervacije.
S klikom na gumb "V redu" boste potrdili zgoraj izbrano prevzemno mesto in naslov za dostavo ter dokončali postopek rezervacije.
S klikom na gumb "V redu" boste potrdili zgoraj izbrani naslov za dostavo in dokončali postopek rezervacije.
Obvestilo
Trenutno je storitev za avtomatsko prijavo in rezervacijo nedostopna. Gradivo lahko rezervirate sami na portalu Biblos ali ponovno poskusite tukaj kasneje.
Gesla v Splošnem geslovniku COBISS
Izbira mesta prevzema
Gradivo iz matične enote je brezplačno. Če je gradivo na mesto prevzema dostavljeno iz drugih enot, lahko knjižnica to storitev zaračuna.
Mesto prevzema | Status gradiva | Rezervacija |
---|
Rezervacija v teku
Prosimo, počakajte trenutek.
Rezervacija je uspela.
Rezervacija ni uspela.
Rezervacija...
Članska izkaznica:
Mesto prevzema: